Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders

Movement Disorders

Volumn 25, Issue 8, 2010, Pages 1068-1076

  Peralta, Victor ^a   Campos, Maria S ^a   De Jalón, Elena García ^a   Cuesta, Manuel J ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Antipsychotics; Catatonic signs; Extrapyramidal signs; Factor structure; Motor abnormalities; Schizophrenia

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; OLANZAPINE; RISPERIDONE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CATALEPSY; CATATONIA; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DYSKINESIA; FACTORIAL ANALYSIS; FEMALE; HUMAN; HYPOKINESIA; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; PARKINSONISM; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT RESPONSE; ADOLESCENT; AGED; DISABILITY; MIDDLE AGED; MOVEMENT DISORDERS; PATHOPHYSIOLOGY; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77953521020     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23050     Document Type: Article

References (51)

1. Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry 1985;147:221-232. (Pubitemid 16255909)
2. Kahlbaum KL. Die Katatonie oder das Spannungirresein. Berlin: Verlag August Hirschwald; 1874.
3. Kraepelin E, Barklay RM. Dementia Praecox and Paraphrenia, Translated by Barklay RM. Edinburgh: Livingstone; 1913.
4. Bleuler E, Zinkin J. Dementia Praecox or the group of Schizophrenias, Translated by Zinkin J. New York, NY: International University Press; 1911.
5. Morrison JR. Changes in subtype diagnosis of schizophrenia: 1920-1966. Am J Psychiatry 1974;131:674-677.
6. Manschreck TC. Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med 1982;12:73-84.
7. Gelenberg AJ, Mandel MR. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977;34:947-950.
8. Ortí-Pareja M, Jímenez-Jímenez JJ, Vázquez A, et al. Drug-induced tardive syndromes. Parkinson Rel Dis 1999;5:59-65.
9. Janno S, Holi M, Tuisju K, et al. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients. Am J Psychiatry 2004;161:160-163. (Pubitemid 38419323)
10. Whitty PF, Owoeye O, Waddington J. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 2009;35:415-424.
11. Pappa S, Dazzan P. Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol Med 2009;39:1065-1076.
12. Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res 1997;27:83-92. (Pubitemid 27465726)
13. Peralta V, Cuesta MJ. Negative, parkinsonian and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 1999;40:245-253.
14. Peralta V, Campos MS, Garcia De Jalon E, et al. The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone or olanzapine. Prim Care Companion J Clin Psychiatry [Epub ahead of print]; doi:10.4088/pcc09m00799gry.
15. Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 2001;49:269-285. (Pubitemid 32453228)
16. Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull, [Epub ahead of print]; doi:10.1093/schbul/sbp105
17. Graybel AM. The basal ganglia and cognitive pattern generators. Schizophr Bull 1997;23:459-467.
18. Shenton ME, Dickey CC, Frumin M, et al. A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
19. Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 2009;66:13-20.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth ed. Washington, D.C.: American Psychiatric Association; 1994.
21. Andreasen NC, Flaum M, Arndt S. The comprehensive assessment of symptoms and diagnosis. An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992;49:615-623.
22. Harris JG. Abbreviated form of the Phillips rating scale of premorbid adjustment in schizophrenia. J Abnorm Psychol 1975;84:129-137.
23. Andreasen NC, Endicott J, Spitzer RL, et al. The family history method using diagnostic criteria. Arch Gen Psychiatry 1977;47:615-621.
24. Perkins DO, Leserman J, Jarskog LF, et al. Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr Res 2000;44:1-10.
25. Guy W. The efficacy index. ECDEU assessment manual for psychopharmacology. US Washington, DC: Government Printing Office; 1976.
26. Mcneil TF, Sjöström K. The McNeil-Sjöström scale for obstetric complications. Malmö, Sweden: Lund University Department of Psychiatry; 1995.
27. Lund CE, Mortimer AM, Rogers D, et al. Motor, volitional and behavioural disorders in schizophrenia, Part 1: assessment using the Modified Rogers Scale. Br J Psychiatry 1991;158:323-327.
28. Mckenna PJ, Lund C, Mortimer A, et al. Motor, volitional and behavioral disorders in schizophrenia, Part 2: the 'conflict of paradigms' hypothesis. Br J Psychiatry 1991;158:328-336.
29. Starkstein SE, Petracca G, Tesón A, et al. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiat 1996;60:326-332. (Pubitemid 26081147)
30. Peralta V, Cuesta MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res 2001;47:107-116.
31. Northoff G, Koch A, Wenke J, Eckert J, et al. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord 1999;14:404-416.
32. Simpson GM, Angus JWS. A rating scale for extrapyramidal side-effects. Acta Psychiat Scand 1970;212: (suppl. 44)11-19.
33. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-676.
34. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835.
35. Chouinard G, Jones B, Remington G, et al. A Canadian multi-center placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993;13:25-40. (Pubitemid 23030357)
36. Honer WG, Kopala LC, Rabinowitz J. Extrapyramidal symptoms and signs in first-episode, antipsychotic-exposed and non-exposed patients with schizophrenia or related psychotic illness. J Psychopharmachol 2005;19:277-285. (Pubitemid 40694946)
37. Krüger S, Bagby RM, Höffler J, et al. Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups. Comp Psychiatry 2003;44:472-482. (Pubitemid 37420716)
38. Ungvary GS, Goggings W, Leung SK, et al. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome. Prog Neuro-Psychopharmacol Biol Psychiatry 2007;31:462-468.
39. Fenton WS, Wyatt RJ, Mcglashan TH. Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry 1994;51:643-650. (Pubitemid 24249106)
40. Peralta V, Cuesta MJ, Serrano JF, Martinez-Larrea JA. Classification issues in catatonia. Eur Arch Psychiatry Clin Neurosci 2001;251: (Suppl 1)14-16.
41. Obeso JA, Rodríguez-Oroz MC, Rodríguez M, et al. The basal ganglia and disorders of movement: pathophysiological mechanisms. News Psysiol Sci 2002;17:51-55.
42. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis: linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 2005;79:59-68. (Pubitemid 41362593)
43. Laruelle M, Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol 1999;13:358-371. (Pubitemid 30055180)
44. Hietala J, Syvälahti E, Vuorio K, et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 1995;346:1130-1131.
45. Mateos JJ, Lomeña F, Parellada E, et al. Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait. Psychopharmachology 2007;191:805-811.
46. Schmitt GJE, Meisenzahl EM, Frodl T, et al. Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [123I]IBZM SPECT. Psychiatry Res Neuroimaging 2009;173:183-189.
47. Dao-Castellana MH, Paillere-Martinot ML, Hantraye P, et al. Presynaptic dopaminergic function in the striatum of schizophrenia patients. Schizophr Res 1997;23:167-174.
48. Elkashef AM, Doudet D, Bryant T, et al. 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography. Psychiatry Res 2000;100:1-11.
49. Utter AM, Basso MA. The basal ganglia: an overview of circuits and function. Neurosci Biobehav Rev 2008;32:333-342.
50. Andreasen NC, Paradiso S, O'leary DS. 'Cognitive dysmetria' as integrative theory of schizophrenia: a dysfunction in cortical-subcortical- cerebellar circuitry?. Schizophr Bull 1998;24:203-218.
51. Mehler-Wex C, Riederer P, Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit disorder. Neurotox Res 2006;10:167-179.